Table 3.
Genotype distribution of the TNF-α G-308A and TGF-β1 C-509T polymorphisms in patient and control groups.
| Gene Polymorphism | Genotype | Controls n (%) | Patients n (%) | χ2 | p Value | OR | 95% CI |
|---|---|---|---|---|---|---|---|
|
| |||||||
| TNF-α G-308A | G | 29 (65.9) | 24 (58.5) | ||||
| GA+AA | 15 (34.1) | 17 (41.5) | 0.491 | 0.483 | 1.369 | 0.658–3.302 | |
|
| |||||||
| TGF-β1 C-509T | CC+CT | 35 (79.5) | 32 (78.05) | ||||
| TT | 9 (20.5) | 9 (21.95) | 0.028 | 0.866 | 1.094 | 0.386–3.097 | |
| CC | 13 (29.5) | 9 (21.95) | |||||
| CC+TT | 31 (70.5) | 32 (78.05) | 0.638 | 0.424 | 1.491 | 0.558–3.985 | |
OR: odds ratio; 95% CI: 95% confidence interval.